Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Biochemistry
|
February 24, 2007
Developmentally regulated demethylase activity targeting the betaA-globin gene in primary avian erythroid cells
Kavitha Ramachandran, Jane van Wert, Gopal Gopisetty, et al.
The Canadian Journal of Urology
|
June 28, 2007
The emerging role of epigenetics in urological cancers
Kavitha Ramachandran, Mark S Soloway, Rakesh Singal, et al.
Biotechniques
|
December 16, 2004
Chromatin immunoprecipitation assay
Partha M Das, Kavitha Ramachandran, Jane vanWert, et al.
Journal of Family Medicine and Primary Care
|
March 30, 2023
Is the National Institute of Health Stroke Scale a valid prognosticator of the aftermath in patients with ischemic stroke?
Kavitha Ramachandran, Devarajan Radha, Archana Gaur, et al.
Anticancer Research
|
January 2, 2016
Role of DNA Methylation in Cabazitaxel Resistance in Prostate Cancer
Kavitha Ramachandran, Carl Speer, Lubov Nathanson, et al.
Anticancer Research
|
November 2, 2010
Methylation-mediated silencing of TMS1 in pancreatic cancer and its potential contribution to chemosensitivity
Kavitha Ramachandran, Heather Miller, Edna Gordian, et al.
Anticancer Research
|
May 1, 2007
Methylation-mediated silencing of genes is not altered by selenium treatment of prostate cancer cells
Kavitha Ramachandran, Loida Navarro, Edna Gordian, et al.
Indian Journal of Surgical Oncology
|
May 17, 2021
Role of CAIX Expression in Conventional Renal Cell Carcinomas as a Diagnostic Marker and its Prognostic Importance
Kavitha Ramachandran, Bindhu M R, Annie Jojo, et al.
Anticancer Research
|
October 15, 2013
Free circulating DNA as a biomarker of prostate cancer: comparison of quantitation methods
Kavitha Ramachandran, Carl G Speer, Stephanie Fiddy, et al.
Clinical Genitourinary Cancer
|
September 3, 2014
Phase I/II study of azacitidine, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel-based therapy
Rakesh Singal, Kavitha Ramachandran, Edna Gordian, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Biochemistry
|
February 24, 2007
Developmentally regulated demethylase activity targeting the betaA-globin gene in primary avian erythroid cells
Kavitha Ramachandran, Jane van Wert, Gopal Gopisetty, et al.
The Canadian Journal of Urology
|
June 28, 2007
The emerging role of epigenetics in urological cancers
Kavitha Ramachandran, Mark S Soloway, Rakesh Singal, et al.
Biotechniques
|
December 16, 2004
Chromatin immunoprecipitation assay
Partha M Das, Kavitha Ramachandran, Jane vanWert, et al.
Journal of Family Medicine and Primary Care
|
March 30, 2023
Is the National Institute of Health Stroke Scale a valid prognosticator of the aftermath in patients with ischemic stroke?
Kavitha Ramachandran, Devarajan Radha, Archana Gaur, et al.
Anticancer Research
|
January 2, 2016
Role of DNA Methylation in Cabazitaxel Resistance in Prostate Cancer
Kavitha Ramachandran, Carl Speer, Lubov Nathanson, et al.
Anticancer Research
|
November 2, 2010
Methylation-mediated silencing of TMS1 in pancreatic cancer and its potential contribution to chemosensitivity
Kavitha Ramachandran, Heather Miller, Edna Gordian, et al.
Anticancer Research
|
May 1, 2007
Methylation-mediated silencing of genes is not altered by selenium treatment of prostate cancer cells
Kavitha Ramachandran, Loida Navarro, Edna Gordian, et al.
Indian Journal of Surgical Oncology
|
May 17, 2021
Role of CAIX Expression in Conventional Renal Cell Carcinomas as a Diagnostic Marker and its Prognostic Importance
Kavitha Ramachandran, Bindhu M R, Annie Jojo, et al.
Anticancer Research
|
October 15, 2013
Free circulating DNA as a biomarker of prostate cancer: comparison of quantitation methods
Kavitha Ramachandran, Carl G Speer, Stephanie Fiddy, et al.
Clinical Genitourinary Cancer
|
September 3, 2014
Phase I/II study of azacitidine, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel-based therapy
Rakesh Singal, Kavitha Ramachandran, Edna Gordian, et al.
Page
of 3